Humalog Mix50 Kwikpen Suspension for Injection (SC)

Nazione: Filippine

Lingua: inglese

Fonte: FDA (Food And Drug Administration)

Principio attivo:

Insulin Lispro

Commercializzato da:

N/A; Importer: Zuellig Pharma Corporation; Distributor: Zuellig Pharma Corporation

INN (Nome Internazionale):

Insulin Lispro

Dosaggio:

100 Units/mL (3.5 mg/mL) Suspension for Injection (SC) (50% Insulin Lispro and 50% Insulin Lispro Protamine)

Forma farmaceutica:

Suspension for Injection (SC)

Confezione:

3 mL Type I pre-filled clear glass pen [Kwikpen] sealed with red halobutyl plunger at the bottom of the cartridge + bilayer elastomeric disc seal [Product contact layer: grey halobutyl and non-product contact layer: red isoprene] at the top (Box of 5's), 3 mL Type I pre-filled clear glass pen [Kwikpen] sealed with red halobutyl plunger at the bottom of the cartridge + bilayer elas

Prodotto da:

Eli Lilly Italia S.p.A., Italy

Dettagli prodotto:

100 Units/mL (3.5 mg/mL) Suspension for Injection (SC) (50% Insulin Lispro and 50% Insulin Lispro Protamine)

Data dell'autorizzazione:

2022-10-28